LA
NFH.WS

Linden Advisors’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Linden Advisors’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-164,603
Closed -$478K – 930
2021
Q4 		$478K Hold
164,603
– – ﹤0.01% 555
2021
Q3 		$457K Hold
164,603
– – ﹤0.01% 481
2021
Q2 		$427K Hold
164,603
– – ﹤0.01% 569
2021
Q1 		$385K Sell
164,603
-4,516
-3% -$10.8K ﹤0.01% 600
2020
Q4 		$365K Hold
169,119
– – ﹤0.01% 442
2020
Q3 		$291K Hold
169,119
– – ﹤0.01% 294
2020
Q2 		$230K Hold
169,119
– – ﹤0.01% 236
2020
Q1 		$176K Hold
169,119
– – ﹤0.01% 217
2019
Q4 		$262K Buy
+169,119
New +$238K ﹤0.01% 212

Linden Advisors's NFH.WS Position: Q1 2022 in Review

Linden Advisors sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2022, closing a stake of 164,603 shares — an estimated $478K sold.

Linden Advisors first reported a position in NFH.WS in Q4 2019 and held it in 9 quarters. The position peaked at $478K in Q4 2021. 0 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2022.

  • Linden Advisors reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2022 after selling out during the quarter.
  • Linden Advisors sold 164,603 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2022, an estimated $478K.
  • Linden Advisors first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 9 quarters.
  • Linden Advisors's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $478K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2022.

Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.